BlackRock’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-249,834
| Closed | -$2.84M | – | 5385 |
|
|
2023
Q4 | $2.84M | Buy |
249,834
+212,895
| +576% | +$2.42M | ﹤0.01% | 3829 |
|
|
2023
Q3 | $149K | Sell |
36,939
-136
| -0.4% | -$548 | ﹤0.01% | 4685 |
|
|
2023
Q2 | $263K | Sell |
37,075
-5,604
| -13% | -$39.8K | ﹤0.01% | 4578 |
|
|
2023
Q1 | $318K | Sell |
42,679
-15,413
| -27% | -$115K | ﹤0.01% | 4574 |
|
|
2022
Q4 | $422K | Sell |
58,092
-33,303
| -36% | -$242K | ﹤0.01% | 4569 |
|
|
2022
Q3 | $886K | Sell |
91,395
-2,653
| -3% | -$25.7K | ﹤0.01% | 4434 |
|
|
2022
Q2 | $1.8M | Sell |
94,048
-86,921
| -48% | -$1.66M | ﹤0.01% | 4210 |
|
|
2022
Q1 | $8.99M | Buy |
180,969
+9,536
| +6% | +$474K | ﹤0.01% | 3558 |
|
|
2021
Q4 | $12.9M | Sell |
171,433
-1,885
| -1% | -$142K | ﹤0.01% | 3456 |
|
|
2021
Q3 | $13.7M | Buy |
173,318
+1,988
| +1% | +$157K | ﹤0.01% | 3466 |
|
|
2021
Q2 | $23.8M | Buy |
171,330
+4,575
| +3% | +$635K | ﹤0.01% | 3146 |
|
|
2021
Q1 | $34.9M | Buy |
166,755
+30,334
| +22% | +$6.35M | ﹤0.01% | 2808 |
|
|
2020
Q4 | $22.7M | Buy |
136,421
+23,024
| +20% | +$3.82M | ﹤0.01% | 2869 |
|
|
2020
Q3 | $19.3M | Buy |
113,397
+13,285
| +13% | +$2.26M | ﹤0.01% | 2807 |
|
|
2020
Q2 | $16.6M | Buy |
100,112
+19,765
| +25% | +$3.28M | ﹤0.01% | 2847 |
|
|
2020
Q1 | $9.3M | Buy |
80,347
+34,664
| +76% | +$4.01M | ﹤0.01% | 2987 |
|
|
2019
Q4 | $6.76M | Buy |
45,683
+13,484
| +42% | +$1.99M | ﹤0.01% | 3373 |
|
|
2019
Q3 | $4.4M | Buy |
32,199
+2,794
| +10% | +$382K | ﹤0.01% | 3479 |
|
|
2019
Q2 | $3.82M | Buy |
29,405
+20,124
| +217% | +$2.62M | ﹤0.01% | 3554 |
|
|
2019
Q1 | $879K | Buy |
+9,281
| New | +$879K | ﹤0.01% | 3905 |
|